1. Home
  2. OCS vs WOLF Comparison

OCS vs WOLF Comparison

Compare OCS & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • WOLF
  • Stock Information
  • Founded
  • OCS 2003
  • WOLF 1987
  • Country
  • OCS Switzerland
  • WOLF United States
  • Employees
  • OCS N/A
  • WOLF N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • WOLF Semiconductors
  • Sector
  • OCS Health Care
  • WOLF Technology
  • Exchange
  • OCS Nasdaq
  • WOLF Nasdaq
  • Market Cap
  • OCS 916.3M
  • WOLF 843.2M
  • IPO Year
  • OCS N/A
  • WOLF 1993
  • Fundamental
  • Price
  • OCS $21.41
  • WOLF $6.84
  • Analyst Decision
  • OCS Strong Buy
  • WOLF Hold
  • Analyst Count
  • OCS 5
  • WOLF 16
  • Target Price
  • OCS $28.80
  • WOLF $14.86
  • AVG Volume (30 Days)
  • OCS 64.5K
  • WOLF 18.8M
  • Earning Date
  • OCS 03-17-2025
  • WOLF 01-29-2025
  • Dividend Yield
  • OCS N/A
  • WOLF N/A
  • EPS Growth
  • OCS N/A
  • WOLF N/A
  • EPS
  • OCS N/A
  • WOLF N/A
  • Revenue
  • OCS $1,027,571.00
  • WOLF $776,600,000.00
  • Revenue This Year
  • OCS $7.98
  • WOLF N/A
  • Revenue Next Year
  • OCS $853.39
  • WOLF $28.15
  • P/E Ratio
  • OCS N/A
  • WOLF N/A
  • Revenue Growth
  • OCS N/A
  • WOLF N/A
  • 52 Week Low
  • OCS $10.55
  • WOLF $4.66
  • 52 Week High
  • OCS $23.08
  • WOLF $30.86
  • Technical
  • Relative Strength Index (RSI)
  • OCS 52.07
  • WOLF 55.11
  • Support Level
  • OCS $20.95
  • WOLF $4.92
  • Resistance Level
  • OCS $21.86
  • WOLF $7.67
  • Average True Range (ATR)
  • OCS 0.56
  • WOLF 0.55
  • MACD
  • OCS -0.26
  • WOLF 0.24
  • Stochastic Oscillator
  • OCS 56.18
  • WOLF 69.64

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

Share on Social Networks: